Investment & M&A transaction comps
Wellness Investment & M&A Transaction Comps
Explore investment and M&A transactions tagged wellness. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.
Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.
- Reviewed transactions
- 21
- With value data
- 10
- With revenue multiples
- 8
- Transaction years
- 2015–2026
Sortable transaction comps
Wellness transaction table
Rows with reported value
11 / 21
Acquisition EV, USD
USD 70B
Investment EV, USD
USD 500M
Median EV / revenue
3.7x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
21 shown of 21 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Twinlab Control | 2026-09-02 | cbdMD | Undisclosed Consideration | Undisclosed | - | - | - | Confirmed 4 sources | ||
| Jamieson Wellness Control (100%) | 2026-08-06 | Kirin Holdings Company | CAD 2.5B Enterprise Value | 1,785 | - | - | Canada | Confirmed 1 source | ||
| Thorne Control | 2026-08-04 | Procter & Gamble | USD 3.8B Consideration | 3,800 | 7.6x | - | United States | Estimated 3 sources | ||
| MADE Group Control (49%) | 2026-06-22 | Danone | Undisclosed | Undisclosed | - | - | Australia | Confirmed 1 source | ||
| Imaraïs Beauty Control | 2026-05-18 | Healthy Extracts | USD 20.0M Consideration | 20 | - | - | - | Confirmed 1 source | ||
| Tally Health Control | 2026-04-29 | Infinite Epigenetics | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Grüns Control (80%) | 2026-04-09 | Unilever | EUR 959M Enterprise Value | 1,120 | 3.7x | - | United States | Estimated 7 sources | ||
| Zywie Ventures Private Limited (OZiva) Control (49%) | 2026-02-12 | Hindustan Unilever Limited (HUL) | INR 17B Enterprise Value | 186 | 3.5x | - | India | Confirmed 6 sources | ||
| Kenvue Control (100%) | 2025-11-03 | Kimberly-Clark | USD 49B Enterprise Value | 48,700 | 3.2x | 14.3x | United States | Confirmed 4 sources | ||
| DUDE Wipes Minority | 2025-06-23 | TSG Consumer | USD 500M Equity Value | 500 | 2.3x | 13.0x | United States | Confirmed 4 sources | ||
| Nutraceutical Wellness, Inc. (Nutrafol) Minority (20%) | 2025-04-01 | Unilever | Undisclosed Investment Amount | Undisclosed | - | - | - | Confirmed 5 sources | ||
| Zywie Ventures Private Limited (OZiva) Control (51%) | 2023-01-10 | Unilever PLC | Undisclosed | Undisclosed | - | - | - | Confirmed 6 sources | ||
| Chr. Hansen Holding Control | 2022-12-12 | Novozymes | USD 12B | 12,300 | 9.3x | 26.2x | Denmark | Confirmed 1 source | ||
| Onnit Lab Inc. Control (100%) | 2021-05-28 | Unilever PLC | Undisclosed | Undisclosed | - | - | United States | Confirmed 11 sources | ||
| Welly Control | 2021-02 | Unilever | Undisclosed | Undisclosed | - | - | United States | Confirmed 2 sources | ||
| Liquid I.V. Control | 2020-09 | Unilever | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| Vital Proteins Control | 2020-06-10 | Nestlé Health Science | Undisclosed | Undisclosed | 4.3x | - | - | Confirmed 1 source | ||
| Probiotics International Control | 2018-07-02 | ADM | USD 243M Consideration | 243 | 5.6x | 21.2x | United Kingdom | Estimated 2 sources | ||
| Equilibra Control | 2018-06 | Unilever | Undisclosed | Undisclosed | - | - | Italy | Confirmed 2 sources | ||
| Swisse Control (83%) | 2015-09-17 | Biostime | AUD 1.7B Enterprise Value | 1,197 | 3.6x | 10.2x | Australia | Confirmed 3 sources |
Explore related tags
Continue to the full transaction history for each tag.
Explore buyers & investors
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.